These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 26598907)

  • 1. Impact of intravenous contrast enhancement phase on target definition for hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (IHC): Observations from patients enrolled on a prospective phase 2 trial.
    Niska JR; Keane FK; Wolfgang JA; Hahn PF; Wo JY; Zhu AX; Hong TS
    Pract Radiat Oncol; 2016; 6(1):e9-16. PubMed ID: 26598907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4D-CT imaging with synchronized intravenous contrast injection to improve delineation of liver tumors for treatment planning.
    Beddar AS; Briere TM; Balter P; Pan T; Tolani N; Ng C; Szklaruk J; Krishnan S
    Radiother Oncol; 2008 Jun; 87(3):445-8. PubMed ID: 18194819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small intrahepatic peripheral cholangiocarcinomas as mimics of hepatocellular carcinoma in multiphasic CT.
    Mendiratta-Lala M; Park H; Kolicaj N; Mendiratta V; Bassi D
    Abdom Radiol (NY); 2017 Jan; 42(1):171-178. PubMed ID: 27590067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of mass-forming intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma: based on the multivariate analysis of contrast-enhanced computed tomography findings.
    Zhao YJ; Chen WX; Wu DS; Zhang WY; Zheng LR
    Abdom Radiol (NY); 2016 May; 41(5):978-89. PubMed ID: 27193795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma and intrahepatic peripheral cholangiocarcinoma: enhancement patterns with quadruple phase helical CT--a comparative study.
    Loyer EM; Chin H; DuBrow RA; David CL; Eftekhari F; Charnsangavej C
    Radiology; 1999 Sep; 212(3):866-75. PubMed ID: 10478259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic contrast-enhanced ultrasound (DCE-US) for the characterization of hepatocellular carcinoma and cholangiocellular carcinoma.
    Wildner D; Pfeifer L; Goertz RS; Bernatik T; Sturm J; Neurath MF; Strobel D
    Ultraschall Med; 2014 Dec; 35(6):522-7. PubMed ID: 25202903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratumoral artery on contrast-enhanced computed tomography imaging: differentiating intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma.
    Tsunematsu S; Chuma M; Kamiyama T; Miyamoto N; Yabusaki S; Hatanaka K; Mitsuhashi T; Kamachi H; Yokoo H; Kakisaka T; Tsuruga Y; Orimo T; Wakayama K; Ito J; Sato F; Terashita K; Nakai M; Tsukuda Y; Sho T; Suda G; Morikawa K; Natsuizaka M; Nakanishi M; Ogawa K; Taketomi A; Matsuno Y; Sakamoto N
    Abdom Imaging; 2015 Aug; 40(6):1492-9. PubMed ID: 25579172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility and potential benefits of defining the internal gross tumor volume of hepatocellular carcinoma using contrast-enhanced 4D CT images obtained by deformable registration.
    Xu H; Gong G; Wei H; Chen L; Chen J; Lu J; Liu T; Zhu J; Yin Y
    Radiat Oncol; 2014 Oct; 9():221. PubMed ID: 25319176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral mass-forming cholangiocarcinoma in cirrhotic liver.
    Kim SJ; Lee JM; Han JK; Kim KH; Lee JY; Choi BI
    AJR Am J Roentgenol; 2007 Dec; 189(6):1428-34. PubMed ID: 18029881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CEUS in hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma in 320 patients - early or late washout matters: a subanalysis of the DEGUM multicenter trial.
    Wildner D; Bernatik T; Greis C; Seitz K; Neurath MF; Strobel D
    Ultraschall Med; 2015 Apr; 36(2):132-9. PubMed ID: 25812115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Radiological Differentiation of Hypervascular Intrahepatic Cholangiocarcinoma from Hepatocellular Carcinoma with a Focus on the CT Value on Multi-phase Enhanced CT.
    Sano S; Yamamoto Y; Sugiura T; Okamura Y; Ito T; Ashida R; Ohgi K; Aramaki T; Nakanuma Y; Uesaka K
    Anticancer Res; 2018 Sep; 38(9):5505-5512. PubMed ID: 30194209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations.
    Schellhaas B; Wildner D; Pfeifer L; Goertz RS; Hagel A; Neurath MF; Strobel D
    Ultraschall Med; 2016 Dec; 37(6):627-634. PubMed ID: 27486793
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: Imaging for Diagnosis, Tumor Response to Treatment and Liver Response to Radiation.
    Lo EC; N Rucker A; Federle MP
    Semin Radiat Oncol; 2018 Oct; 28(4):267-276. PubMed ID: 30309637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis.
    Iavarone M; Piscaglia F; Vavassori S; Galassi M; Sangiovanni A; Venerandi L; Forzenigo LV; Golfieri R; Bolondi L; Colombo M
    J Hepatol; 2013 Jun; 58(6):1188-93. PubMed ID: 23485522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computed tomography features of an intraductal polypoid mass: differentiation between hepatocellular carcinoma with bile duct tumor invasion and intraductal papillary cholangiocarcinoma.
    Jung AY; Lee JM; Choi SH; Kim SH; Lee JY; Kim SW; Han JK; Choi BI
    J Comput Assist Tomogr; 2006; 30(1):18-24. PubMed ID: 16365567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective comparison of computed tomography and magnetic resonance imaging for liver cancer delineation using deformable image registration.
    Voroney JP; Brock KK; Eccles C; Haider M; Dawson LA
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):780-91. PubMed ID: 17011453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
    Hong TS; Wo JY; Yeap BY; Ben-Josef E; McDonnell EI; Blaszkowsky LS; Kwak EL; Allen JN; Clark JW; Goyal L; Murphy JE; Javle MM; Wolfgang JA; Drapek LC; Arellano RS; Mamon HJ; Mullen JT; Yoon SS; Tanabe KK; Ferrone CR; Ryan DP; DeLaney TF; Crane CH; Zhu AX
    J Clin Oncol; 2016 Feb; 34(5):460-8. PubMed ID: 26668346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CT features of an intraductal polypoid mass: Differentiation between hepatocellular carcinoma with bile duct tumor invasion and intraductal papillary cholangiocarcinoma.
    Jung AY; Lee JM; Choi SH; Kim SH; Lee JY; Kim SW; Han JK; Choi BI
    J Comput Assist Tomogr; 2006; 30(2):173-81. PubMed ID: 16628028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interobserver variability in target volume delineation of hepatocellular carcinoma : An analysis of the working group "Stereotactic Radiotherapy" of the German Society for Radiation Oncology (DEGRO).
    Gkika E; Tanadini-Lang S; Kirste S; Holzner PA; Neeff HP; Rischke HC; Reese T; Lohaus F; Duma MN; Dieckmann K; Semrau R; Stockinger M; Imhoff D; Kremers N; Häfner MF; Andratschke N; Nestle U; Grosu AL; Guckenberger M; Brunner TB
    Strahlenther Onkol; 2017 Oct; 193(10):823-830. PubMed ID: 28695316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-enhanced ultrasound (CEUS) for differentiating between hepatocellular and cholangiocellular carcinoma.
    Bohle W; Clemens PU; Heubach T; Zoller WG
    Ultraschall Med; 2012 Dec; 33(7):E191-E195. PubMed ID: 22194045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.